α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

FA Van de Laar, PL Lucassen, RP Akkermans… - Diabetes …, 2005 - Am Diabetes Assoc
OBJECTIVE—To review the effects of monotherapy with α-glucosidase inhibitors (AGIs) for
patients with type 2 diabetes, with respect to mortality, morbidity, glycemic control, insulin …

Diabetes and the risk of tuberculosis: a neglected threat to public health?

CR Stevenson, JA Critchley, NG Forouhi… - Chronic …, 2007 - journals.sagepub.com
Objectives: Tuberculosis (TB) remains a major global public health problem. In the past, a
relationship between TB and diabetes mellitus (DM) was recognized, and its importance …

Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing …

T Heise, J Chien, JM Beals, C Benson… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of
basal insulin Fc (BIF; LY3209590), a fusion protein combining a novel single‐chain insulin …

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a …

SJ Griffin, K Borch-Johnsen, MJ Davies, K Khunti… - The Lancet, 2011 - thelancet.com
Background Intensive treatment of multiple cardiovascular risk factors can halve mortality
among people with established type 2 diabetes. We investigated the effect of early …

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

RK Simmons, JB Echouffo-Tcheugui, SJ Sharp… - The Lancet, 2012 - thelancet.com
Background The increasing prevalence of type 2 diabetes poses a major public health
challenge. Population-based screening and early treatment for type 2 diabetes could reduce …

Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy

MIK El-Sayed - Journal of ethnopharmacology, 2011 - Elsevier
Ethnpharmacological relevance: To investigate antidiabetic activity of purslane seeds on
type-2 diabetic subjects and to provide scientific basis for the clinical use of Portulaca …

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017

S Wilkinson, I Douglas, H Stirnadel-Farrant… - BMJ open, 2018 - bmjopen.bmj.com
Objectives Guidelines for the use of drugs for type 2 diabetes mellitus (T2DM) have changed
since 2000, and new classes of drug have been introduced. Our aim was to describe how …

Exercise prescription in the treatment of type 2 diabetes mellitus: current practices, existing guidelines and future directions

C O'hagan, G De Vito, CAG Boreham - Sports Medicine, 2013 - Springer
Exercise is an effective treatment for type 2 diabetes mellitus, resulting in stabilization of
plasma glucose in the acute phase and improvements in body composition, insulin …

Social support and glycemic control in type 2 diabetes: a systematic review of observational studies

R Stopford, K Winkley, K Ismail - Patient education and counseling, 2013 - Elsevier
Objective We aim to systematically review observational studies examining the association
between social support and glycemic control in adults with type 2 diabetes. Methods We …

Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes

AD Timmis, BR Chaitman, M Crager - European heart journal, 2006 - academic.oup.com
Aims The anti-anginal efficacy and safety of ranolazine in diabetic and non-diabetic patients
included in the Combination Assessment of Ranolazine In Stable Angina (CARISA) trial …